H.R. 3884 · 118th Congress

Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023

Stage
Passed a chamber
Sponsor
Michael Burgess
Introduced
2023-06-07
Latest action
2024-09-24 · Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Action history

  1. 2024-09-24Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
  2. 2024-09-23Motion to reconsider laid on the table Agreed to without objection.
  3. 2024-09-23On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.
  4. 2024-09-23DEBATE - The House proceeded with forty minutes of debate on H.R. 3884.
  5. 2024-09-23Considered under suspension of the rules.
  6. 2024-09-23Mr. Bucshon moved to suspend the rules and pass the bill, as amended.
  7. 2023-08-25Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 118-166.
  8. 2023-08-25Placed on the Union Calendar, Calendar No. 132.
  9. 2023-07-19Committee Consideration and Mark-up Session Held.
  10. 2023-07-19Ordered to be Reported (Amended) by the Yeas and Nays: 50 - 0.
  11. 2023-07-13Forwarded by Subcommittee to Full Committee (Amended) by the Yeas and Nays: 28 - 0.
  12. 2023-07-13Subcommittee Consideration and Mark-up Session Held
  13. 2023-06-09Referred to the Subcommittee on Health.
  14. 2023-06-07Introduced in House
  15. 2023-06-07Referred to the House Committee on Energy and Commerce.